cabozantinib,ipilimumab,lenvatinib,avelumab,nivolumab,pembrolizumab,axitinib
merck,pfizer,eisai,bms
['samurai', 'rcc,(-irccs),(-srcc),(-urcc)']
nrg-gu012: randomized phase ii stereotactic ablative radiation therapy (sabr) for patients with metastatic unresected #rcc receiving immunotherapy #samurai. presented by . #asco23 written coverage by &gt; 
Largest global online community of #urological medical professionals & patients. #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology